Luxturna gene therapy

Luxturna gene therapy

Credit: OHSU News

Surgeons Andreas Lauer, M.D., (left) and Steven Bailey, M.D., (at scope) prepare to inject the Luxturna into Caspian Soto's eye. Soto is among first in Oregon to have new treatment for rare, blindness-causing genetic mutation, September 17, 2018 at the OHSU Casey Eye Institute in Portland, Oregon. (OHSU/Kristyna Wentz-Graff)

Download Photo (11.6 MB)

Facebook Twitter LinkedIn YouTube Instagram OHSU Braille services OHSU sign language services OHSU interpreter services X